Axogen AXGN
NASDAQ AXGN
$47.27 +0.58 (+1.24%)
As of: Sep 9, 2026 · 3:59 PM EDT

Axogen (AXGN) Total Debt Growth (1y) (2011 - 2025)

Analysis

Axogen (AXGN) Total Debt Growth (1y) (2011 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 142.67%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -1.59%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -9.88%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 8.95%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 0.12%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -9.07%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 12.29%
10 Axogen 2.51 Bn 2.40 Bn 50.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.88%
Sep 30, 2025 1.88%
Jun 30, 2025 1.89%
Mar 31, 2025 1.90%
Dec 31, 2024 1.92%
Sep 30, 2024 1.93%
Jun 30, 2024 1.93%
Mar 31, 2024 1.95%
Dec 31, 2023 1.95%
Sep 30, 2023 1.96%
Jun 30, 2023 1.97%
Mar 31, 2023 1.98%
Dec 31, 2022 1.99%
Sep 30, 2022 -1.62%
Jun 30, 2022 -1.78%
Mar 31, 2022 40.14%
Dec 31, 2021 39.95%
Sep 30, 2021 34.74%
Mar 31, 2021 980.70%
Dec 31, 2020 1,744.87%